Potassium Iodide is a thyroid blocking agent that protects the body from absorbing radioactive iodine released from a damaged nuclear power plant or an atomic bomb.
  iOSAT™ is the first radiation protective tablet available to the general public. Experts agree that its prompt use would be the most effective measure available to protect millions of people who would be at risk in a nuclear accident or under a radiation threat from a terrorist nuclear weapon. These FDA approved tablets contain potassium iodide (KI) which provides virtually complete protection from radioactive iodine [ RAI ], the contaminant that causes thyroid cancer.

  IOSAT is fully FDA approved for thyroid blocking in a radiation emergency.

  IOSAT tablets received approval from the United States Food and Drug Administration in 1982, and is the only full strength tablet for radiation blocking which may legally be sold in the United States. Only iOSAT has passed all FDA tests for purity, quality, safety, and efficiency.

   Each standard package of IOSAT contains a strip of 14 tablets, with each tablet containing 130 mg of potassium iodide. The tablets are double scored to split easily and cleanly into 65 and 32.5 child doses.
   The recommended dosage: Adults and children 1 year of age or older: One (1) tablet once a day. Crush for small children. Babies under 1 year of age: One-half (1/2) tablet once a day. Crush first. To be taken 30 minutes prior to exposure.

* Use only as directed by state or local public health authorities in the event of a radiation emergency.
* Store at room temperature.
* Keep package dry and foil packets intact.
* 7 year shelf life
* Supplies are limited, so place your order now